MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202527035160 A) filed by Shanghai Henlius Biotech Inc.; Shanghai Henlius Biopharmaceutical Co. Ltd.; and Shanghai Henlius Biologics Co. Ltd., Shanghai, on April 10, for 'anti b7h3 antibodies and methods of use.'
Inventor(s) include Chang Jen Kuan; Xu Wenfeng; Jiang Wei Dong; Issafras Hassan; Xue Jie; and Lin Pei Hua.
The application for the patent was published on May 30, under issue no. 22/2025.
According to the abstract released by the Intellectual Property India: "The present application discloses antibodies and antibody derivatives that bind to B7H3 (also known as CD276) and methods of using the same. The antibodies or antibody derivatives comprise a single domain antibody that binds to B7H3."
The patent application was internationally filed on Sept. 21, 2023, under International application No.PCT/CN2023/120292.
Disclaimer: Curated by HT Syndication.
